Guidelines for the treatment of autoimmune neuromuscular transmission disorders

Important progress has been made in our understanding of the cellular and molecular processes underlying the autoimmune neuromuscular transmission (NMT) disorders; myasthenia gravis (MG), Lambert–Eaton myasthenic syndrome (LEMS) and neuromyotonia (peripheral nerve hyperexcitability; Isaacs syndrome)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology 2006-07, Vol.13 (7), p.691-699
Hauptverfasser:	Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Hart, I. K., Harms, L., Hilton-Jones, D., Melms, A., Verschuuren, J., Horge, H. W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Autoimmune Diseases of the Nervous System - therapy Azathioprine - therapeutic use Humans Immunosuppressive Agents - therapeutic use Lambert-Eaton myasthenic syndrome Lambert-Eaton Myasthenic Syndrome - therapy MEDLINE - statistics & numerical data myasthenia gravis Myasthenia Gravis - therapy Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Neuromuscular Junction Diseases - therapy neuromuscular transmission disorders neuromyotonia Plasma Exchange - methods Thymectomy - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!